HUP0100066A2 - Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére - Google Patents

Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére

Info

Publication number
HUP0100066A2
HUP0100066A2 HU0100066A HUP0100066A HUP0100066A2 HU P0100066 A2 HUP0100066 A2 HU P0100066A2 HU 0100066 A HU0100066 A HU 0100066A HU P0100066 A HUP0100066 A HU P0100066A HU P0100066 A2 HUP0100066 A2 HU P0100066A2
Authority
HU
Hungary
Prior art keywords
diol
alpha
mixture
skin diseases
hydroxy acid
Prior art date
Application number
HU0100066A
Other languages
English (en)
Inventor
Agneta Ganemo
Original Assignee
Yamanouchi Europe B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe B.V. filed Critical Yamanouchi Europe B.V.
Publication of HUP0100066A2 publication Critical patent/HUP0100066A2/hu
Publication of HUP0100066A3 publication Critical patent/HUP0100066A3/hu
Publication of HU226065B1 publication Critical patent/HU226065B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya egy diol és egy alfa-hidroxisav keverékéttartalmazó készítménynek egy félig felszívódó vivőanyagban történőalkalmazása hiperkeratózisos bőrbetegségek helyi kezelésére. Ó
HU0100066A 1997-11-25 1998-11-25 Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bõrbetegségek kezelésére szolgáló gyógyszer elõállítására HU226065B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (3)

Publication Number Publication Date
HUP0100066A2 true HUP0100066A2 (hu) 2001-08-28
HUP0100066A3 HUP0100066A3 (en) 2006-07-28
HU226065B1 HU226065B1 (hu) 2008-04-28

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100066A HU226065B1 (hu) 1997-11-25 1998-11-25 Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bõrbetegségek kezelésére szolgáló gyógyszer elõállítására

Country Status (22)

Country Link
US (1) US6399082B1 (hu)
EP (1) EP1032378B1 (hu)
CN (1) CN1140266C (hu)
AT (1) ATE213939T1 (hu)
AU (1) AU754420B2 (hu)
BG (1) BG64743B1 (hu)
BR (1) BR9815016A (hu)
CA (1) CA2310049C (hu)
CZ (1) CZ290165B6 (hu)
DE (1) DE69804130T2 (hu)
DK (1) DK1032378T3 (hu)
ES (1) ES2174533T3 (hu)
HK (1) HK1034194A1 (hu)
HU (1) HU226065B1 (hu)
IS (1) IS2147B (hu)
NO (1) NO320100B1 (hu)
NZ (1) NZ504458A (hu)
PL (1) PL190023B1 (hu)
PT (1) PT1032378E (hu)
SK (1) SK284505B6 (hu)
TR (1) TR200001486T2 (hu)
WO (1) WO1999026617A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
WO1999060167A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
EP1996021B1 (en) 2006-02-28 2017-12-13 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20110021618A1 (en) * 2008-03-25 2011-01-27 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2404156T3 (es) * 2009-04-13 2013-05-24 Vanangamudi Subramaniam SULUR Una crema medicinal con ácido fusídico hecha utilizando fusidato de sodio e incorporando un biopolímero y el proceso para hacerla
AU2010244983B2 (en) * 2009-05-08 2015-07-16 Allmedic Pty Ltd Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
AU2011323271B2 (en) * 2010-11-04 2016-10-27 442 Ventures, Llc Composition and method for treating skin conditions
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
EP0719133A1 (en) * 1993-09-15 1996-07-03 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
IS5505A (is) 2000-05-23
SK284505B6 (sk) 2005-05-05
EP1032378B1 (en) 2002-03-06
HUP0100066A3 (en) 2006-07-28
EP1032378A1 (en) 2000-09-06
ATE213939T1 (de) 2002-03-15
BR9815016A (pt) 2000-10-03
CZ290165B6 (cs) 2002-06-12
DK1032378T3 (da) 2002-04-15
IS2147B (is) 2006-09-15
SK7432000A3 (en) 2001-05-10
DE69804130D1 (de) 2002-04-11
CZ20001920A3 (cs) 2001-04-11
NO20002649L (no) 2000-07-24
US6399082B1 (en) 2002-06-04
CN1280495A (zh) 2001-01-17
PT1032378E (pt) 2002-07-31
CN1140266C (zh) 2004-03-03
ES2174533T3 (es) 2002-11-01
CA2310049C (en) 2008-02-19
CA2310049A1 (en) 1999-06-03
HK1034194A1 (en) 2001-10-19
DE69804130T2 (de) 2002-07-25
TR200001486T2 (tr) 2001-07-23
AU754420B2 (en) 2002-11-14
WO1999026617A1 (en) 1999-06-03
PL340679A1 (en) 2001-02-12
HU226065B1 (hu) 2008-04-28
NO320100B1 (no) 2005-10-24
BG64743B1 (bg) 2006-02-28
AU1965999A (en) 1999-06-15
NZ504458A (en) 2002-03-01
NO20002649D0 (no) 2000-05-24
PL190023B1 (pl) 2005-10-31
BG104470A (en) 2001-03-30

Similar Documents

Publication Publication Date Title
HUP0100066A2 (hu) Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére
HUP0003784A2 (hu) Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény
DE69421778D1 (de) Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut
ATE229502T1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE3889346D1 (de) Mittel zur Arzneistoffabgabe und Verfahren zu deren Herstellung.
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
DE69805438D1 (de) Misch- und ladeöffnung zur medizinischen behandlung
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
DE59508360D1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
ID22416A (id) Komposisi-komposisi farmasi yang mengandung ibuprofen dan domperidon untuk pengobatan migrain
ZA9711468B (en) New use of comt inhibitors
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ID15946A (id) Turunan-turunan diaril alkana yang mengandung gugus alisiklik pembuatan dan penggunaan terapi serta profilaktiknya
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE69712287D1 (de) Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden
DE69824670D1 (de) TCF-II für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
DE59708286D1 (de) Verwendung von wirkstoffmischungen, enthaltend phytostenole und/oder phytostenolester und potenzierungsmittel zur herstellung von hypocholesterinämischen mitteln
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA25095A (uk) Ліhімеhт для лікуваhhя каhдидозhого і змішаhого вульвовагіhіту

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ASTELLAS PHARMA EUROPE B.V., NL

Free format text: FORMER OWNER(S): YAMANOUCHI EUROPE B.V., NL; ASTELLAS PHARMA EUROPE B.V., NL

GB9A Succession in title

Owner name: LEO PHARMA A/S, DK

Free format text: FORMER OWNER(S): YAMANOUCHI EUROPE B.V., NL; ASTELLAS PHARMA EUROPE B.V., NL; ASTELLAS PHARMA EUROPE B.V., NL

MM4A Lapse of definitive patent protection due to non-payment of fees